No Stomach For Cancer Foundation Q&A
No Stomach For Cancer Foundation aims to advance awareness about stomach cancer; provide a support network for affected families; and encourage research efforts for early detection, screening and prevention of the disease.
LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer, Available at Biologics by McKesson
CARY, N.C., June 11, 2021 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, […]
Cholangiocarcinoma Foundation Q&A
The Cholangiocarcinoma Foundation is the largest foundation that serves cholangiocarcinoma. It is dedicated to educating and supporting patients by providing the personal guidance and tools they need to navigate this complex disease.
Video Transcript: Patient Spotlight – Cherie T.
Biologics by McKesson Patient Voice Spotlight – Cherie T. Cherie T., Biologics by McKesson Oncology Patient: Twenty-one years ago, I […]
Video Transcript: Patient Spotlight – Nicole B.
Biologics by McKesson Patient Voice Spotlight – Nicole B. Nicole B., Biologics by McKesson Oncology Patient: I was first diagnosed […]
Video Transcript: Patient Spotlight – Karen I.
Biologics by McKesson Patient Voice Spotlight – Karen I. Karen I., Biologics by McKesson Oncology Patient: I was diagnosed in […]
Video Transcript: Patient Spotlight – Larry H.
Biologics by McKesson Patient Voice Spotlight – Larry H. Larry H., Biologics by McKesson Oncology Patient: I was diagnosed in […]
NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson
CARY, N.C., April 19, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]
SYNGAP1 Foundation Q&A
The SYNGAP1 Foundation was founded in 2014. Today, it is the leading non-profit patient advocacy group dedicated to improving the quality of life for patients and families affected by the rare SYNGAP1 gene mutation or a variant.
FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson
CARY, N.C., March 11, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]